Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
EVH
EVH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EVH News
EVOLENT HEALTH: OPPENHEIMER LOWERS PRICE TARGET FROM $12 TO $6
Mar 02 2026
moomoo
Evolent Health to Participate in Investor Conferences
Feb 26 2026
PRnewswire
Evolent Health Q4 2025 Earnings Call Insights
Feb 25 2026
seekingalpha
KeyBanc Downgrades Evolent Health Rating Amid EBITDA Concerns
Feb 25 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Feb 25 2026
Benzinga
Evolent Health Q4 Earnings Analysis and Outlook
Feb 25 2026
stocktwits
Evolent Health Reports Revenue Decline in Q4 2025
Feb 25 2026
NASDAQ.COM
Evolent Health Reports Increased Losses in Q4 Earnings
Feb 25 2026
NASDAQ.COM
Evolent Health Reports Financial Results for FY 2025
Feb 24 2026
PRnewswire
Evolent Health to Announce Q4 Earnings on February 24
Feb 23 2026
seekingalpha
Evolent Health to Release Q4 and Year-End 2025 Financial Results
Feb 04 2026
PRnewswire
Evolent Health to Release Q4 and Year-End Results on February 24, 2026
Feb 04 2026
Newsfilter
Evolent Health Appoints New CFO Mario Ramos with $2.35M Stock Award
Jan 02 2026
Newsfilter
Evolent Health Grants CFO Mario Ramos $2.35M Inducement Award
Jan 02 2026
PRnewswire
Evolent Health (EVH) Faces Downgrade from Canaccord Due to Rising Short-Term Uncertainty and Confusion in Medicare/Medicaid Enrollment
Dec 16 2025
Yahoo Finance
Citigroup Reaffirms Buy Rating on Evolent Health, Adjusts Price Target to $9.5
Nov 21 2025
Benzinga
Show More News
